Latest News about RNA
Recent news which mentions RNA
From Benzinga
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
December 20, 2024
From Benzinga
What 8 Analyst Ratings Have To Say About Avidity Biosciences
December 20, 2024
Tickers
RNA
From Benzinga
Assessing Avidity Biosciences: Insights From 10 Financial Analysts
November 13, 2024
Tickers
RNA
From Benzinga
Evaluating Avidity Biosciences: Insights From 10 Financial Analysts
October 21, 2024
Tickers
RNA
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 07, 2024
From Benzinga
Why Avidity Biosciences Zoomed to a 12% Gain This Week
October 04, 2024
From Motley Fool
Goldman Sachs Bullish On Avidity Biosciences, Cites Scalable RNA Therapeutics Platform For Rare Diseases
September 24, 2024
From Benzinga
Fulcrum Therapeutics Upgraded: BofA Debates Pivotal Study Success For Losmapimod In Rare Genetic Muscle Disease
September 09, 2024
From Benzinga
Tickers
RNA
From InvestorPlace
Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday
August 09, 2024
From Benzinga
From InvestorPlace
From Motley Fool
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing
July 18, 2024
From Benzinga
Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
July 01, 2024
From Benzinga
From Benzinga
From Benzinga
Crude Oil Moves Higher; Vera Bradley Shares Slide
June 12, 2024
From Benzinga
Why Streamline Health Solutions Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 12, 2024
From Benzinga
From Benzinga
Nasdaq Jumps 300 Points; Oracle Shares Spike Higher
June 12, 2024
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|